Danaher Corporation

Fortive Schedules Fourth Quarter 2020 Earnings Conference Call

Friday, January 15, 2021 - 9:15pm

Fortive Corporation (Fortive) (NYSE: FTV) today announced that it will webcast its earnings conference call for the fourth quarter 2020 on Thursday, February 4, 2021 beginning at 5:30 p.m.

Key Points: 
  • Fortive Corporation (Fortive) (NYSE: FTV) today announced that it will webcast its earnings conference call for the fourth quarter 2020 on Thursday, February 4, 2021 beginning at 5:30 p.m.
  • ET and notifying the operator that you are dialing in for Fortives earnings conference call (access code 5897681).
  • A replay of the conference call will be available two hours after the conclusion of the call until Thursday, February 18, 2020.
  • This quiet period will be in place until fiscal fourth quarter 2020 earnings are released on February 4, 2021.

Vontier Announces Pricing of Secondary Equity Offering of Remaining Shares of Common Stock Held by Fortive

Wednesday, January 13, 2021 - 11:24pm

Vontier Corporation (Vontier) (NYSE: VNT) today announced the pricing of its previously announced underwritten offering of 33,507,410 shares of its common stock, representing all of the shares of Vontier common stock currently owned by Fortive Corporation (Fortive), Vontiers former parent company, at a price to the public of $33.50 per share.

Key Points: 
  • Vontier Corporation (Vontier) (NYSE: VNT) today announced the pricing of its previously announced underwritten offering of 33,507,410 shares of its common stock, representing all of the shares of Vontier common stock currently owned by Fortive Corporation (Fortive), Vontiers former parent company, at a price to the public of $33.50 per share.
  • Fortive has agreed to exchange all of the shares of Vontier common stock to be sold in the offering for indebtedness of Fortive owned by Goldman Sachs & Co. LLC.
  • Fortive has exchanged the shares of Vontier common stock to be sold in the offering for indebtedness of Fortive owned by Goldman Sachs & Co. LLC.
  • Following the completion of the offering, Fortive will no longer own any shares of common stock of Vontier.

Danaher CEO To Comment On Financial Performance

Wednesday, January 13, 2021 - 11:59am

Mr. Blair will communicate that fourth quarter 2020 core revenue growth including Cytiva is expected to be above the Company's previously announced guidance, driven primarily by better performance in its Life Sciences and Diagnostics segments.

Key Points: 
  • Mr. Blair will communicate that fourth quarter 2020 core revenue growth including Cytiva is expected to be above the Company's previously announced guidance, driven primarily by better performance in its Life Sciences and Diagnostics segments.
  • For the fourth quarter 2020, estimated revenues increased approximately 38.5% year-over-year, with approximately 15.0% estimated non-GAAP core revenue growth including Cytiva.
  • As previously announced, Danaher will hold its quarterly earnings conference call for the fourth quarter and year-end 2020 on Thursday, January 28, 2021 at 8:00 a.m.
  • Danaher is a global science and technology innovator committed to helping its customers solve complex challenges and improving quality of life around the world.

Vontier Announces Launch of Secondary Equity Offering of Remaining Shares of Common Stock Held by Fortive

Tuesday, January 12, 2021 - 9:04pm

Vontier Corporation (Vontier) (NYSE: VNT) today announced the commencement of an underwritten offering of 33,507,410 shares of its common stock, representing all of the shares of Vontier common stock currently owned by Fortive Corporation (Fortive), Vontiers former parent company.

Key Points: 
  • Vontier Corporation (Vontier) (NYSE: VNT) today announced the commencement of an underwritten offering of 33,507,410 shares of its common stock, representing all of the shares of Vontier common stock currently owned by Fortive Corporation (Fortive), Vontiers former parent company.
  • Vontier is not selling any shares and will not receive any proceeds from the sale of the shares in the offering or the debt-for-equity exchange (as described below).
  • Prior to the closing of the offering, Fortive intends to exchange the shares of Vontier common stock to be sold in the offering for indebtedness of Fortive currently owned by Goldman Sachs & Co. LLC.
  • Goldman Sachs & Co. LLC, as the selling stockholder in the offering, then intends to sell these shares of Vontier common stock to the underwriters in connection with the public offering.

Danaher Schedules Fourth Quarter 2020 Earnings Conference Call

Thursday, January 7, 2021 - 9:15pm

WASHINGTON, Jan. 7, 2021 /PRNewswire/ --Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the fourth quarter 2020 on Thursday, January 28, 2021 beginning at 8:00 a.m.

Key Points: 
  • WASHINGTON, Jan. 7, 2021 /PRNewswire/ --Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the fourth quarter 2020 on Thursday, January 28, 2021 beginning at 8:00 a.m.
  • You can access the conference call by dialing 866-503-8675 within the U.S. or +1 786-815-8792 outside the U.S. a few minutes before 8:00 a.m.
  • ET and notifying the operator that you are dialing in for Danaher's earnings conference call (access code 7971317).
  • A replay of the conference call will be available shortly after the conclusion of the call until February 11, 2021.

Danaher To Present At J.P. Morgan Healthcare Conference

Thursday, January 7, 2021 - 9:15pm

WASHINGTON, Jan. 7, 2021 /PRNewswire/ --Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the J.P. Morgan Healthcare Conference on Wednesday, January 13, 2021 at 10:50 a.m.

Key Points: 
  • WASHINGTON, Jan. 7, 2021 /PRNewswire/ --Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the J.P. Morgan Healthcare Conference on Wednesday, January 13, 2021 at 10:50 a.m.
  • The audio will be simultaneously webcast on and the presentation will be archived on www.danaher.com .
  • Danaher is a global science and technology innovator committed to helping its customers solve complex challenges and improving quality of life around the world.
  • Its family of world class brands has leadership positions in the demanding and attractive health care, environmental and applied end-markets.

Global Forensic Technologies Market to Grow by $ 8.88 Billion During 2020-2024 | Featuring AB SCIEX LLC, Agilent Technologies Inc., and Cytiva among others | Technavio

Thursday, December 31, 2020 - 3:29am

Technavio estimates the global forensic technologies market to grow by USD 8.88 billion, progressing at a CAGR of over 8% during the forecast period.

Key Points: 
  • Technavio estimates the global forensic technologies market to grow by USD 8.88 billion, progressing at a CAGR of over 8% during the forecast period.
  • The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment.
  • View the full release here: https://www.businesswire.com/news/home/20201230005399/en/
    Technavio has announced its latest market research report titled Global Forensic Technologies Market 2020-2024 (Graphic: Business Wire)
    The market is driven by the demand for better investigation methods.
  • Major Three Forensic Technologies Market Vendors:
    AB SCIEX LLC operates its business through the Unified product segment.

Danaher Announces Executive Appointment

Monday, December 21, 2020 - 9:15pm

WASHINGTON, Dec. 21, 2020 /PRNewswire/ --Danaher Corporation (NYSE: DHR) announced today that Jose-Carlos ("JC") Gutierrez-Ramos has been named Senior Vice President and Chief Scientific Officer for Danaher.

Key Points: 
  • WASHINGTON, Dec. 21, 2020 /PRNewswire/ --Danaher Corporation (NYSE: DHR) announced today that Jose-Carlos ("JC") Gutierrez-Ramos has been named Senior Vice President and Chief Scientific Officer for Danaher.
  • With this appointment, Dr. Gutierrez-Ramos will become an executive officer of the Company and report directly to Rainer M. Blair, President and Chief Executive Officer.
  • The depth of his experience combined with his innovation leadership will be important contributions as we continue to build a stronger, better Danaher.
  • Dr. Gutierrez-Ramos joins Danaher from Abbvie where he served as the Head of Global Drug Discovery and was a member of the executive R&D team.

$5.5 Bn Lab Automation Markets: Robotic Arm, Microplate Readers, Workstation, LIMS, ELN - Global Report 2020-2025 - ResearchAndMarkets.com

Tuesday, December 15, 2020 - 1:30pm

The "Lab Automation Market by Product (Robotic Arm, Microplate Readers, Workstation, LIMS, ELN), Application (Drug Discovery, Diagnostics, Genomics, Proteomics, Microbiology), End-User (Pharma, Diagnolab, Forensics, Environmental) - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Lab Automation Market by Product (Robotic Arm, Microplate Readers, Workstation, LIMS, ELN), Application (Drug Discovery, Diagnostics, Genomics, Proteomics, Microbiology), End-User (Pharma, Diagnolab, Forensics, Environmental) - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.
  • The growth of the market is attributed to increasing spending on pharmaceutical R&D, growing food safety concerns, stringent regulation in healthcare.
  • Moreover, the growing proteomics market, rising environmental safety concerns, and high demand in emerging nations offer lucrative opportunities for the market players.
  • The leading players in the lab automation market are Thermo Fisher Scientific (US), Agilent Technologies (US),Tecan Group (Switzerland),PerkinElmer Inc. (US) and Danaher Corporation (US).

Danaher announces leadership appointment

Monday, December 14, 2020 - 1:00pm

With this appointment, Ms. Honeycutt will become an executive officer of the Company.

Key Points: 
  • With this appointment, Ms. Honeycutt will become an executive officer of the Company.
  • Prior to this appointment, Ms. Honeycutt, 51 years old, was a Vice President and Group Executive overseeing Pall, IDT, and the Danaher Life Sciences platform in China, and served as President of Pall.
  • The combination of Jennifer's strong operational track record, innovative mindset and commitment to the Danaher Business System has enabled her to make a tremendous impact.
  • Its family of world class brands has leadership positions in the demanding and attractive health care, environmental and applied end-markets.